What the Numbers Say: Semaglutide vs
To investigate further, the MHRA and UK Biobank are working together to understand if there is a genetic link between GLP-1s and drug-induced acute pancreatitis, similar to that with immunosuppressant drug thiopurine
Semaglutide is injected just under the skin (subcutaneously) in your abdomen or thigh
Semaglutide: First global approval
Reporting their findings in The BMJ [2] (online, 20 October 2016 ) , the team found that there was a similar level of breast cancer risk among the 498 patients who used GLP-1 analogues, such as liraglutide and exenatide, and the 2,422 patients who used DPP-4 inhibitors, at 4.4 and 3.4 per 1,000 person-years, respectively
Most patients shift to monthly injections after initial weekly repletion